These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia. Andia I, Zumarraga M, Zabalo MJ, Bulbena A, Davila R. Biol Psychiatry; 1998 Jan 01; 43(1):20-3. PubMed ID: 9442340 [Abstract] [Full Text] [Related]
25. Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients. Yoshimura R, Ueda N, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J. World J Biol Psychiatry; 2010 Mar 01; 11(2 Pt 2):256-61. PubMed ID: 20218790 [Abstract] [Full Text] [Related]
26. Perspectives on a time-dependent model of neuroleptic action. Pickar D. Schizophr Bull; 1988 Mar 01; 14(2):255-68. PubMed ID: 2904694 [Abstract] [Full Text] [Related]
27. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics. Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D. Arch Gen Psychiatry; 1993 Aug 01; 50(8):606-14. PubMed ID: 7688209 [Abstract] [Full Text] [Related]
28. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia. Davila R, Gonzalez MA, Zumarraga M, Andia I, Guimon J, Silva RR, Friedhoff AJ. Biol Psychiatry; 1995 Aug 15; 38(4):267-9. PubMed ID: 8547450 [No Abstract] [Full Text] [Related]
32. Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine. Nikisch G, Baumann P, Kiessling B, Reinert M, Wiedemann G, Kehr J, Mathé AA, Piel M, Roesch F, Weisser H, Schneider P, Hertel A. J Psychiatr Res; 2010 Sep 15; 44(12):754-9. PubMed ID: 20176367 [Abstract] [Full Text] [Related]
33. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation. Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL. Arch Gen Psychiatry; 1991 Jan 15; 48(1):73-6. PubMed ID: 1670618 [Abstract] [Full Text] [Related]
35. Assessment of the central dopaminergic index of plasma HVA in schizophrenia. Amin F, Davidson M, Kahn RS, Schmeidler J, Stern R, Knott PJ, Apter S. Schizophr Bull; 1995 Jan 15; 21(1):53-66. PubMed ID: 7770741 [Abstract] [Full Text] [Related]
39. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy. Hori H, Yoshimura R, Katsuki A, Atake K, Igata R, Konishi Y, Nakamura J. World J Biol Psychiatry; 2017 Aug 15; 18(5):401-408. PubMed ID: 27409727 [Abstract] [Full Text] [Related]
40. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Arch Gen Psychiatry; 1991 Oct 15; 48(10):910-3. PubMed ID: 1929760 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]